Advertisement
Screener

Inari Medical, Inc. Operating Cash Flow

Inari Medical, Inc. Operating Cash Flow

Inari Medical, Inc. reported Operating Cash Flow of $1.94 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-10-28.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2024-10-28

  • Inari Medical, Inc. net cash provided by (used in) operating activities for the quarter ending 2024-09-30 was $2.71M, a 82.99% decline year-over-year.
  • Inari Medical, Inc. net cash provided by (used in) operating activities for the quarter ending 2024-06-30 was $11.51M, a 17.96% increase year-over-year.
  • Inari Medical, Inc. net cash provided by (used in) operating activities for the quarter ending 2024-03-31 was -$12.29M.
  • Inari Medical, Inc. net cash provided by (used in) operating activities for the quarter ending 2023-12-31 was $12.24M, a 8.76% increase year-over-year.
  • Inari Medical, Inc. net cash provided by (used in) operating activities for fiscal 2023 was $35.93M.
  • Inari Medical, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$13.97M, a 154.82% decline from fiscal 2021.
  • Inari Medical, Inc. net cash provided by (used in) operating activities for fiscal 2021 was $25.49M, a 1232.95% increase from fiscal 2020.
  • Inari Medical, Inc. net cash provided by (used in) operating activities for fiscal 2020 was $1.91M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 12 month
2024-09-30$2.71M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-28
$14.22M
derived: sum of 2 quarters · filed 2024-10-28
$1.94M
10-Q · filed 2024-10-28
$14.18M
derived: sum of 4 quarters · filed 2024-10-28
2024-06-30$11.51M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30
-$775.00K
10-Q · filed 2024-07-30
$11.47M
derived: sum of 3 quarters · filed 2024-07-30
$27.41M
derived: sum of 4 quarters · filed 2024-10-28
2024-03-31-$12.29M
10-Q · filed 2024-04-30
-$47.00K
derived: sum of 2 quarters · filed 2024-04-30
$15.89M
derived: sum of 3 quarters · filed 2024-10-28
$25.65M
derived: sum of 4 quarters · filed 2024-10-28
2023-12-31$12.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
$28.18M
derived: sum of 2 quarters · filed 2024-10-28
$37.94M
derived: sum of 3 quarters · filed 2024-10-28
$35.93M
10-K · filed 2024-02-29
2023-09-30$15.94M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-28
$25.70M
derived: sum of 2 quarters · filed 2024-10-28
$23.69M
10-Q · filed 2024-10-28
$34.94M
derived: sum of 4 quarters · filed 2024-10-28
2023-06-30$9.76M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30
$7.75M
10-Q · filed 2024-07-30
$19.00M
derived: sum of 3 quarters · filed 2024-07-30
$5.94M
derived: sum of 4 quarters · filed 2024-07-30
2023-03-31-$2.01M
10-Q · filed 2024-04-30
$9.24M
derived: sum of 2 quarters · filed 2024-04-30
-$3.82M
derived: sum of 3 quarters · filed 2024-04-30
-$6.88M
derived: sum of 4 quarters · filed 2024-04-30
2022-12-31$11.26M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
-$1.81M
derived: sum of 2 quarters · filed 2024-02-29
-$4.87M
derived: sum of 3 quarters · filed 2024-02-29
-$13.97M
10-K · filed 2024-02-29
2022-09-30-$13.07M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01
-$16.13M
derived: sum of 2 quarters · filed 2023-11-01
-$25.23M
10-Q · filed 2023-11-01
-$10.22M
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30-$3.06M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02
-$12.16M
10-Q · filed 2023-08-02
$2.85M
derived: sum of 3 quarters · filed 2024-02-29
-$2.74M
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31-$9.10M
10-Q · filed 2023-05-03
$5.91M
derived: sum of 2 quarters · filed 2024-02-29
$318.00K
derived: sum of 3 quarters · filed 2024-02-29
$7.62M
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31$15.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
$9.42M
derived: sum of 2 quarters · filed 2024-02-29
$16.72M
derived: sum of 3 quarters · filed 2024-02-29
$25.49M
10-K · filed 2024-02-29
2021-09-30-$5.59M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02
$1.71M
derived: sum of 2 quarters · filed 2022-11-02
$10.48M
10-Q · filed 2022-11-02
$8.86M
derived: sum of 4 quarters · filed 2023-02-27
2021-06-30$7.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03
$16.07M
10-Q · filed 2022-08-03
$14.44M
derived: sum of 3 quarters · filed 2023-02-27
$19.79M
derived: sum of 4 quarters · filed 2023-02-27
2021-03-31$8.77M
10-Q · filed 2022-05-04
$7.14M
derived: sum of 2 quarters · filed 2023-02-27
$12.48M
derived: sum of 3 quarters · filed 2023-02-27
$11.36M
derived: sum of 4 quarters · filed 2023-02-27
2020-12-31-$1.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27
$3.72M
derived: sum of 2 quarters · filed 2023-02-27
$2.59M
derived: sum of 3 quarters · filed 2023-02-27
$1.91M
10-K · filed 2023-02-27
2020-09-30$5.34M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
$4.21M
derived: sum of 2 quarters · filed 2021-11-09
$3.54M
10-Q · filed 2021-11-09
$2.71M
derived: sum of 4 quarters · filed 2022-02-23
2020-06-30-$1.13M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10
-$1.80M
10-Q · filed 2021-08-10
-$2.63M
derived: sum of 3 quarters · filed 2022-02-23
-$2.97M
derived: sum of 4 quarters · filed 2022-02-23
2020-03-31-$679.00K
10-Q · filed 2021-05-11
-$1.50M
derived: sum of 2 quarters · filed 2022-02-23
-$1.84M
derived: sum of 3 quarters · filed 2022-02-23
2019-12-31-$826.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23
-$1.16M
derived: sum of 2 quarters · filed 2022-02-23
-$4.94M
10-K · filed 2022-02-23
2019-09-30-$335.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12
-$4.11M
10-Q · filed 2020-11-12
2019-06-30-$3.77M
10-Q · filed 2020-08-11
2018-12-31-$10.89M
10-K · filed 2021-03-09